Blackrock Neurotech

This moment is the most exciting time in the history of neuroscience —and Blackrock Neurotech is on the precipice. We’ve developed and deployed brain-computer interface (BCI) technology that is in patients now – and has the potential to help millions of people affected by neurological disease and disabilities caused by paralysis, ALS, and spinal cord injuries.

We were the first to take the leap into human research, and are years ahead of our competitors, with the first BCI in humans and the only FDA-cleared platform for the neurological treatment of hearing, movement, and direct-to-brain communications. Of the 35 people around the world who have an implanted BCI, 31 of them use Blackrock technology.

As the global leader in this transformative technology, our mission is simple: to help people walk, talk, hear, and see again.

Learn more at www.blackrockneuro.com.